Inogen (INGN) Acquisitions (2017)
Inogen's (INGN) quarterly Acquisitions came in at $47000.0 in Q4 2017, up 840.0% on a QoQ basis from $5000.0 in Q3 2017.
Inogen (INGN) Acquisitions (2017) Analysis & Trends
Inogen (INGN) has 1 years of Acquisitions data on file, last reported at $47000.0 in Q4 2017.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $47000.0 in Q4 2017; TTM through Dec 2023 was $52000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $29.6 million, changed N/A from the prior year.
- Acquisitions for Q4 2017 stood at $47000.0, up from $5000.0 in the prior quarter.
- Over the last five years, Acquisitions for INGN reached as high as $47000.0 in Q4 2017 and fell as low as $5000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -268.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 47,000.00 |
| Sep 30, 2017 | 5,000.00 |